tiprankstipranks
Ligand Pharmaceuticals Inc (LGND)
NASDAQ:LGND
US Market
Want to see LGND full AI Analyst Report?

Ligand Pharma (LGND) Technical Analysis

850 Followers

Technical Sentiment

Overall Consensus
Buy
8Bullish
0Neutral
5Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ligand Pharmaceuticals Inc’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is 8.00, suggesting Ligand Pharmaceuticals Inc is a Buy.
Ligand Pharmaceuticals Inc’s (LGND) 20-Day exponential moving average is 297.43, while Ligand Pharmaceuticals Inc’s (LGND) share price is $300.53, making it a Sell.
Ligand Pharmaceuticals Inc’s (LGND) 50-Day exponential moving average is 279.27, while Ligand Pharmaceuticals Inc’s (LGND) share price is $300.53, making it a Buy.

Ligand Pharma (LGND) Pivot Points

Aug 01, 2026, 04:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Aug 01, 2026, 04:38 AM
Period
Simple
Exponential
MA5
295.72Buy
295.66Buy
MA10
298.79Sell
298.03Sell
MA20
305.20Sell
297.43Sell
MA50
274.85Buy
279.27Buy
MA100
245.23Buy
254.91Buy
MA200
219.70Buy
226.10Buy
Ligand Pharmaceuticals Inc’s (LGND) 10-Day exponential moving average is 298.03, while Ligand Pharmaceuticals Inc’s (LGND) share price is $300.53, making it a Sell.
Ligand Pharmaceuticals Inc’s (LGND) 100-Day exponential moving average is 254.91, while Ligand Pharmaceuticals Inc’s (LGND) share price is $300.53, making it a Buy.
Ligand Pharmaceuticals Inc’s (LGND) stock price is $300.53 and Ligand Pharmaceuticals Inc’s (LGND) 50-day simple moving average is 274.85, creating a Buy signal.
Ligand Pharmaceuticals Inc’s (LGND) stock price is $300.53 and Ligand Pharmaceuticals Inc’s (LGND) 100-day simple moving average is 245.23, creating a Buy signal.
Ligand Pharmaceuticals Inc’s (LGND) stock price is $300.53 and Ligand Pharmaceuticals Inc’s (LGND) 200-day simple moving average is 219.70, creating a Buy signal.

Ligand Pharma (LGND) Technical Indicators

Aug 01, 2026, 04:38 AM
Name
Value
Implied Action
RSI (14)
54.93
Neutral
STOCH (9,6)
47.64
Neutral
STOCHRSI (14)
33.25
Neutral
MACD (12,26)
8.00
Buy
ADX (14)
18.68
Buy
Williams %R
-71.64
Buy
CCI (14)
-57.16
Neutral
ATR (14)
11.19
-
Ultimate Oscillator
47.63
Neutral
ROC
-6.31
Sell
Ligand Pharmaceuticals Inc’s (LGND) Relative Strength Index (RSI) is 54.93, creating a Neutral signal.
Ligand Pharmaceuticals Inc’s (LGND) Trend Strength Indicator (ADX) is 18.68, creating a Buy signal.
Ligand Pharmaceuticals Inc’s (LGND) Commodity Channel Index (CCI) is -57.16, creating a Neutral signal.
Ligand Pharmaceuticals Inc’s (LGND) Price Rate of Change (ROC) is -6.31, creating a Sell signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Buy.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 54.93, which suggests LGND is a Neutral.
      What is LGND’s MACD?
      LGND’s MACD is 8.00, which suggests LGND is a Buy.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 295.72, which suggests LGND is a Buy.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 305.20, which suggests LGND is a Sell.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 274.85, which suggests LGND is a Buy.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 219.70, which suggests LGND is a Buy.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -71.64, which suggests LGND is a Buy.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is -57.16, which suggests LGND is a Neutral.